Amazon removes the series about the healthcare industry after Unitedhealth called it “defamatory”

Documentary series criticizing the United States Healthcare The industry was removed from Amazon platforms from video streams at the beginning of this year after condemning them Unitedhealth for alleged “defamatory”.

Docuseries, developed by the Wisconsin Mary Stuse filmmaker, was removed from the platform after the office employed by Unitedhealth sent a letter to Amazon, which is in favor of removing the series, stating that she defined the healthcare company.

The film was removed from both Amazon and Vimeo platforms as a result of Unitedhealth’s legal efforts. In addition, their actions led to the postponement of the publication of the article conducting an investigation in the case of the company after she sued the media organization about another article, which was supposedly defamatory.

This is the latest tip of a more aggressive campaign adopted by Unitedhealth in order to silence their critics, according to The New York Times. The company began to attack the media, which in any way criticize them, shape or form, arguing that such a critic will encourage violence against its employees after shooting the general director Brian Thompson last year.

This new campaign indicates the increased readiness of companies to impose legal repercussions against critics and critics. Observers noticed that similar campaigns have been growing since the Trump administration adopted power.

“Some versions have been going on for a long time,” said Lee Levine, a retired lawyer from the first amendment who defended information points, including the New York Times. However, “the incidence increased,” he pointed out.

Unitedhealth has recently experienced adverse reactions from the negative press, which is probably a factor motivating their new approach. They are actively dealing with many federal criminal and civil investigations, including investigations on the alleged Medicare fraud and antitrust violations, in accordance with The Wall Street Journal.

“Negative advertising can negatively affect our price of shares, damage our reputation and expose us to unexpected or unjustified regulatory control,” noted Unitedhealth in his latest latest Annual report.